Where this non Hodgkin lymphoma information comes from | Cancer Research UK
Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter

Where this non Hodgkin lymphoma information comes from

Men and women discussing non Hodgkin's lymphoma

On this page are the major sources of information that we use to put together this section of the website.


About this page

All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this list. We also try to find patients to review all our sections. If you have had non Hodgkin lymphoma, live in the UK, and would like to become a patient reviewer, you can write to us by clicking on contact us.



Cancer Research UK
CancerStats Series

US National Cancer Institute
Information on the treatment of non Hodgkin lymphoma



Principles and practice of oncology (9th edition) 
VT De Vita, S Hellman and SA Rosenberg
Lippincott, Williams and Wilkins, 2011

Cancer and its management (6th edition)
J Tobias and D Hochhauser
Wiley-Blackwell 2010

AJCC Cancer Staging Manual (7th edition)
American Joint Committee on Cancer
Springer, 2010


UK and international guidelines

National Institute for Health and Care Excellence (NICE) appraisals
Link to the NICE website

  • Rituximab for the first line treatment of stage 3 or 4 follicular lymphoma, January 2012 
  • Rituximab for the treatment of follicular non Hodgkin's lymphoma (maintenance treatment following response to first-line chemotherapy), June 2011
  • Lymphoma (non Hodgkin's) – bendamustine, October 2010 (Terminated appraisal)
  • Lymphoma (follicular non Hodgkin's) – rituximab, February 2008 
  • Referral Guidelines for Suspected Cancer, June 2015
  • Improving Outcomes in Haematological Cancers – The Manual, October 2003
  • Non Hodgkin's lymphoma – rituximab, September 2003

The Scottish Government
Link to the Scottish Government website

  • Scottish referral guidelines for suspected cancer, February 2007

Scottish Medicines Consortium (SMC) advice
Link to the SMC website

  • Guidance on bendamustine for people who have had rituximab which is no longer working, April 2011
  • Rituximab as maintenance therapy for follicular lymphoma, February 2011
  • Guidance on rituximab as maintenance therapy for relapsed/refractory follicular lymphoma, December 2006
  • Rituximab for stage 3 or 4 follicular lymphoma in combination with CVP chemotherapy, December 2004
  • Guidance on rituximab for CD20 positive diffuse large B cell lymphoma, March 2003

British Committee for Standards in Haematology (BCSH)
Link to the BCSH website

  • Guidelines for the investigation and management of mantle cell lymphoma, 2012
  • The investigation and management of follicular lymphoma, 2011
  • Guidelines for the management of mature T cell lymphoma and NK cell neoplasms, 2011

European Society of Medical Oncology (ESMO)
Link to the ESMO website

  • ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma, 2012

Articles and reviews

Non Hodgkin lymphoma. K Shankland, J Armitage, B Hancock and others. The Lancet. (2012) 380:848-57

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up. M Dreyling, M Ghielmini, R Marcus and others (2011) Annals of Oncology 22 (suppl 6): vi59-63

Gastric Marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up. E Zucca and M Dreyling. (2010) Annals of Oncology 21 (suppl 5): v175-176

Diffuse large B cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up. H Tilly and M Dreyling (2010) Annals of Oncology 21 (suppl 5): v172-174

Personal Use of Hair Dyes and Risk of Cancer: a meta analysis. B Takkouche, M Etminan and A Montes-Martínez. (2005) Journal of the American Medical Association. 293(20): 2516-25.


Specialist reviewers

Dr Nilima Parry-Jones, MD, MRCP, MRCPath (Consultant haematologist)
Dr Christopher McNamara, FRACP, FRCPA, FRCPath (Consultant haematologist)



Dee McLean  ̶̶  MeDee Art, Medical Illustration

Rate this page:
Submit rating
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team

No Error

Updated: 26 September 2014